Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Safeguarding the right to work for people with advanced breast cancer (ABC) and their caregivers: A global snapshot of legislati

Hayley Jones and Sarah McHutchison
Safeguarding the right to work for people with advanced breast cancer (ABC) and their caregivers: A global snapshot of legislati ( Hayley Jones and Sarah McHutchison )
13 Oct 2026

Therapeutic mammoplasty: An advanced oncoplastic breast surgery technique

Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India
Therapeutic mammoplasty: An advanced oncoplastic breast surgery technique ( Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India )
16 Jul 2026

Defining breast cancer quality care around the globe

Dr Didier Verhoeven, Prof Sabine Siesling, Prof Pankaj Gupta Roy & Prof Cary Kaufman
Defining breast cancer quality care around the globe ( Dr Didier Verhoeven, Prof Sabine Siesling, Prof Pankaj Gupta Roy & Prof Cary Kaufman )
1 Jul 2026

Giredestrant plus palbociclib shows limited benefit in ER-positive, HER2-negative metastatic breast cancer

Dr Mabel Mardones - Rocky Mountain Cancer Centers, Denver, USA
Giredestrant plus palbociclib shows limited benefit in ER-positive, HER2-negative metastatic breast cancer ( Dr Mabel Mardones - Rocky Mountain Cancer Centers, Denver, USA )
10 Jun 2026

Sacituzumab govitecan improves PFS across Trop-2, BRCA, and HER2 metastatic triple-negative breast cancer

Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Sacituzumab govitecan improves PFS across Trop-2, BRCA, and HER2 metastatic triple-negative breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
9 Jun 2026

Sacituzumab govitecan plus pembrolizumab improves PFS across biomarker subgroups in metastatic triple-negative breast cancer

Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Sacituzumab govitecan plus pembrolizumab improves PFS across biomarker subgroups in metastatic triple-negative breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
9 Jun 2026

Gedatolisib combinations double PFS vs alpelisib in PIK3CA-mutant advanced breast cancer

Dr Sara Hurvitz - Fred Hutchinson Cancer Center, Seattle, USA
Gedatolisib combinations double PFS vs alpelisib in PIK3CA-mutant advanced breast cancer ( Dr Sara Hurvitz - Fred Hutchinson Cancer Center, Seattle, USA )
2 Jun 2026

Sacituzumab govitecan plus pembrolizumab improves outcomes beyond progression in PD-L1-positive mTNBC

Dr Kevin Kalinsky - Winship Cancer Institute, Atlanta, USA
Sacituzumab govitecan plus pembrolizumab improves outcomes beyond progression in PD-L1-positive mTNBC ( Dr Kevin Kalinsky - Winship Cancer Institute, Atlanta, USA )
2 Jun 2026

ASCO 2026: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ASCO 2026: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
1 Jun 2026

GLP-1 therapy associated with reduced breast cancer risk

Dr Elizabeth McDonald - University of Pennsylvania, Philadelphia, USA
GLP-1 therapy associated with reduced breast cancer risk ( Dr Elizabeth McDonald - University of Pennsylvania, Philadelphia, USA )
1 Jun 2026

Gene expression test guided therapy in ER+/HER2- early breast cancer allows safe chemotherapy omission

Dr Robert Stein - University College London, London, UK
Gene expression test guided therapy in ER+/HER2- early breast cancer allows safe chemotherapy omission ( Dr Robert Stein - University College London, London, UK )
1 Jun 2026

Weight loss intervention improves quality of life in breast cancer survivors

Dr Jennifer Ligibel - Dana-Farber Cancer Institute, Boston, USA
Weight loss intervention improves quality of life in breast cancer survivors ( Dr Jennifer Ligibel - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2026